GlaxoSmithKline (GSK)

Add to Watchlists Create an Alert
49.10 +0.23  +0.47% NYSE Aug 29, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Cash from Financing (TTM):

-10.32B for June 30, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Financing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Financing (TTM) Data

View and export this data going back to 1985. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 -10.32B
March 31, 2014 -11.84B
Dec. 31, 2013 -9.812B
Sept. 30, 2013 -8.819B
June 30, 2013 -8.971B
March 31, 2013 -5.612B
Dec. 31, 2012 -5.310B
Sept. 30, 2012 -5.742B
June 30, 2012 -6.754B
March 31, 2012 -9.848B
Dec. 31, 2011 -9.988B
Sept. 30, 2011 -9.501B
June 30, 2011 -8.162B
March 31, 2011 -8.181B
Dec. 31, 2010 -8.605B
Sept. 30, 2010 -8.964B
June 30, 2010 -5.478B
March 31, 2010 -5.910B
Dec. 31, 2009 -4.329B
Sept. 30, 2009 -5.030B
June 30, 2009 -10.51B
March 31, 2009 -4.377B
Dec. 31, 2008 -8.997B
Sept. 30, 2008 -3.347B
June 30, 2008 -2.681B
   
March 31, 2008 -7.789B
Dec. 31, 2007 -3.487B
Sept. 30, 2007 -8.248B
June 30, 2007 -7.411B
March 31, 2007 -8.176B
Dec. 31, 2006 -8.821B
Sept. 30, 2006 -10.69B
June 30, 2006 -10.14B
March 31, 2006 -4.918B
Dec. 31, 2005 -5.296B
Sept. 30, 2005 -2.465B
June 30, 2005 -2.302B
March 31, 2005 -6.354B
Dec. 31, 2004 -6.240B
Sept. 30, 2004 -7.896B
June 30, 2004 -7.882B
March 31, 2004 -7.488B
Dec. 31, 2003 -6.438B
Sept. 30, 2003 -4.107B
June 30, 2003 -5.577B
March 31, 2003 -6.103B
Dec. 31, 2002 -5.766B
Sept. 30, 2002 -7.042B
June 30, 2002 -4.764B
March 31, 2002 -4.031B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

GSK Cash from Financing (TTM) Benchmarks

Companies
AstraZeneca -3.481B
Pfizer -15.55B
Novartis -9.235B

GSK Cash from Financing (TTM) Range, Past 5 Years

Minimum -11.84B Mar 2014
Maximum -4.329B Dec 2009
Average -7.858B

GSK Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("GSK", "cash_financing_ttm")
  • Last 5 data points: =YCS("GSK", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.